NEW YORK (GenomeWeb) – Thermo Fisher Scientific said this week it has signed a definitive agreement to sell its Cole-Parmer channel business to private equity firm GTCR for $480 million in cash. Cole-Parmer, part of Thermo Fisher's Laboratory Products and Services segment, provides fluid handling, test and measurement, and electrochemistry products and services. It has 400 employees worldwide and recorded $230 million in revenues last year. The deal is expected to close in the third quarter and is anticipated to have no material impact on Thermo Fisher's adjusted EPS.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.